Delivery Order SPE2DB22D3004-SPE2DB24FPH46
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $3.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide $5,359.12 worth of RABAVERT rabies vaccine with diluents. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 2025, to deliver pharmaceutical products and medical supplies to support military treatment programs and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,651.50 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RABAVERT rabies vaccine with diluents. This delivery order does not have a set-aside designation and is scheduled for completion by February 8, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is issued under an indefinite delivery contract (IDC) they hold with DLA. The IDC has...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RABAVERT Rabies Vaccine with diluents. The $9,651.50 award has a performance period through March 5, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) with DLA valued up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,123.33 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide RABAVERT rabies vaccines with diluents. This award has a completion date of February 14, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
- Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, was awarded a firm fixed price delivery order worth $2,316.36 by the Defense Logistics Agency (DLA) to provide RABAVERT rabies vaccine with diluents. The award has a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of RABAVERT rabies vaccine with diluents, with a potential value of $2,895.45 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,246.72 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide RabAvert rabies vaccine with diluents. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,651.50 to provide RABAVERT rabies vaccine with diluents. This award is part of Amerisourcebergen's broader contract vehicle with DLA, an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,572.68 by the Defense Logistics Agency for the supply of Rabavert rabies vaccine with diluents. The contract, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $8,945.46 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS and has an ultimate completion date of May 10, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...